Zhaowu Y. Ma

Nanhuan Road 1
Jingzhou, 434023, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Correction: Harnessing nanomedicine to target NFκB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation.

Correction: Harnessing nanomedicine to target NFκB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation.

Journal: Cell communication and signaling : CCS

Published: February 24, 2026

Harnessing nanomedicine to target NF-κB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation.

Harnessing nanomedicine to target NF-κB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation.

Journal: Cell communication and signaling : CCS

Published: August 12, 2025

The dual facets of MiRNA in modulating NF-κB in breast cancer.

The dual facets of MiRNA in modulating NF-κB in breast cancer.

Journal: Cancer cell international

Published: July 15, 2025

O-GlcNAcylation in novel regulated cell death: ferroptosis, pyroptosis, and necroptosis.

O-GlcNAcylation in novel regulated cell death: ferroptosis, pyroptosis, and necroptosis.

Journal: Cell death discovery

Published: June 03, 2025

The structure and function of FBXW5 in human diseases.

The structure and function of FBXW5 in human diseases.

Journal: Biochemistry and biophysics reports

Published: May 19, 2025

The solute carrier family 11 transporters: a bridge between iron homeostasis and tumor biology.

The solute carrier family 11 transporters: a bridge between iron homeostasis and tumor biology.

Journal: Cell communication and signaling : CCS

Published: April 21, 2025

Suppression of NGALR impedes TNBC cell survival, proliferation, invasion, and migration through Akt/mTOR and JAK/STAT3 pathway inhibition.

Suppression of NGALR impedes TNBC cell survival, proliferation, invasion, and migration through Akt/mTOR and JAK/STAT3 pathway inhibition.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 12, 2025

The role of MUC2 in cancer - Biological significance and therapeutic implications: A review.

The role of MUC2 in cancer - Biological significance and therapeutic implications: A review.

Journal: International journal of biological macromolecules

Published: April 08, 2025

The Role of Cancer Organoids in Ferroptosis, Pyroptosis, and Necroptosis: Functions and Clinical Implications.

The Role of Cancer Organoids in Ferroptosis, Pyroptosis, and Necroptosis: Functions and Clinical Implications.

Journal: Biomolecules

Published: April 04, 2025

Transforming cancer treatment: integrating patient-derived organoids and CRISPR screening for precision medicine.

Transforming cancer treatment: integrating patient-derived organoids and CRISPR screening for precision medicine.

Journal: Frontiers in pharmacology

Published: January 19, 2025

Landscape of Noncoding RNA in the Hypoxic Tumor Microenvironment.

Landscape of Noncoding RNA in the Hypoxic Tumor Microenvironment.

Journal: Genes

Published: January 06, 2025

Protein iron transporters as potential therapeutic targets in cancer: A review.

Protein iron transporters as potential therapeutic targets in cancer: A review.

Journal: International journal of biological macromolecules

Published: January 06, 2025

Showing 1-12 of 63

Last Updated: 09/26/2026